Atlas Trials

Safety and Efficacy Study of Catioprost® (Unpreserved Latanoprost 0.005% Emulsion) Compared to Travatan Z® to Treat Glaucoma and Ocular Surface Disease

Clinical trial NCT01254370 · COMPLETED

Trial details

NCT number
NCT01254370
Sponsor
Santen SAS
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
GlaucomaOcular HypertensionOcular Surface Disease
Start date
2010-11-01
Primary completion
2011-06-01
Enrollment
105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.